Document Detail


Preliminary experience on treatment of infantile hemangioma with low-dose propranolol in China.
MedLine Citation:
PMID:  23340697     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
CONCLUSION: Low-dose propranolol is effective and safe for Chinese children with IH, and larger-scale studies are merited. Mechanisms underlying IH pathogenesis, and possible involvement of the renin-angiotensin-aldosterone system, deserve study.
Authors:
Xiaorong Ma; Tinghui Zhao; Yan Xiao; Jie Yu; Huiping Chen; Yinying Huang; Jun Liu; Jun Lin; Tianxiang Ouyang
Related Documents :
22920497 - Predictors of outcome in neck pain patients undergoing chiropractic care: comparison of...
24892027 - Active-treatment effects of the forsus fatigue resistant device during comprehensive cl...
23432857 - Tuberculosis diagnosed in a rural setting in angola. accuracy of follow-up sputum smear...
23638997 - Efficacy of topical tacrolimus for the treatment of persistent pruritus ani in patients...
16724817 - Syringosubarachnoid shunt for syringomyelia associated with chiari i malformation.
21669567 - Necessity and indications of invasive treatment for budd-chiari syndrome.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2013-01-23
Journal Detail:
Title:  European journal of pediatrics     Volume:  172     ISSN:  1432-1076     ISO Abbreviation:  Eur. J. Pediatr.     Publication Date:  2013 May 
Date Detail:
Created Date:  2013-04-22     Completed Date:  2013-11-18     Revised Date:  2014-07-31    
Medline Journal Info:
Nlm Unique ID:  7603873     Medline TA:  Eur J Pediatr     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  653-9     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenergic beta-Antagonists / administration & dosage,  adverse effects,  therapeutic use*
Aldosterone / blood*
Angiotensin II / blood*
China
Female
Hemangioma / drug therapy*
Humans
Infant
Male
Propranolol / administration & dosage,  adverse effects,  therapeutic use*
Prospective Studies
Renin / blood*
Treatment Outcome
Chemical
Reg. No./Substance:
0/Adrenergic beta-Antagonists; 11128-99-7/Angiotensin II; 4964P6T9RB/Aldosterone; 9Y8NXQ24VQ/Propranolol; EC 3.4.23.15/Renin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Combination therapy of benign prostate syndrome/lower urinary tract symptoms.
Next Document:  Cardiovascular disease in childhood: the role of obesity.